Although we observed solid decitabine-mediated CSPG4-upregulation in over 50% of ovarian cancer cells, long-lasting remissions are predicated on elimination of the whole tumor including all antigen-negative cells. This evidence concerns the gene CSPG4 and ovarian carcinoma.